• English
  • Korean
  • Chinese
表紙
市場調査レポート - 225571

薬剤溶出バルーン(DEB):世界のパイプラン評価、競争環境、2017年までの市場予測

Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

発行 GlobalData
出版日 ページ情報 英文 91 Pages
電子版即納可
価格
薬剤溶出バルーン(DEB):世界のパイプラン評価、競争環境、2017年までの市場予測 Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
出版日: 2011年12月05日 ページ情報: 英文 91 Pages
概要

当レポートでは、薬剤溶出バルーン(DEB)の世界市場の最新動向と将来展望について分析し、製品の機能と特徴、全世界および主要8カ国の市場動向(2003〜2017年の市場収益および販売個数の計測・予測など)、主要企業のプロファイル、市販製品の技術的特徴と治験の状況、開発中の製品のパイプライン評価などの情報を取りまとめ、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 薬剤溶出バルーン用に認可された主な心臓脈管の兆候

  • ステント内再狭窄
  • ステント内再狭窄の疫学:全世界
  • 末梢血管疾患:概要と病態生理学
  • 末梢血管疾患の疫学:全世界
  • 末梢血管疾患:装置を活用した治療法とその成果

第4章 世界市場の特徴

  • 市場収益実績値(2003〜2010年)および予測値(2010〜2017年):全世界
  • 販売個数実績値(2003〜2010年)および予測値(2010〜2017年):全世界
  • 市場のダイナミクス(市場促進・抑制要因)
  • アンメットニーズと機会

第5章 各国市場における市場収益および販売個数(2003〜2017年)

  • 市場収益実績値(2003〜2010年)および予測値(2010〜2017年):ドイツ
  • 販売個数実績値(2003〜2010年)および予測値(2010〜2017年):ドイツ
  • 市場収益実績値(2003〜2010年)および予測値(2010〜2017年):フランス
  • 販売個数実績値(2003〜2010年)および予測値(2010〜2017年):フランス
  • 市場収益実績値(2003〜2010年)および予測値(2010〜2017年):スペイン
  • 販売個数実績値(2003〜2010年)および予測値(2010〜2017年):スペイン
  • 市場収益実績値(2003〜2010年)および予測値(2010〜2017年):イタリア
  • 販売個数実績値(2003〜2010年)および予測値(2010〜2017年):イタリア
  • 市場収益実績値(2003〜2010年)および予測値(2010〜2017年):英国
  • 販売個数実績値(2003〜2010年)および予測値(2010〜2017年):英国
  • 市場収益実績値(2003〜2010年)および予測値(2010〜2017年):オーストラリア
  • 販売個数実績値(2003〜2010年)および予測値(2010〜2017年):オーストラリア
  • 市場収益実績値(2003〜2010年)および予測値(2010〜2017年):中国
  • 販売個数実績値(2003〜2010年)および予測値(2010〜2017年):中国
  • 市場収益実績値(2003〜2010年)および予測値(2010〜2017年):インド
  • 販売個数実績値(2003〜2010年)および予測値(2010〜2017年):インド

第6章 企業シェア分析と主要企業

  • 世界市場での企業シェア(2010年)
  • Braun:企業概要と製品構成
  • Eurocor:企業概要
  • Invatec:企業概要と製品構成
  • Aachen Resonance GmbH:企業概要と製品構成

第7章 PTCA冠動脈薬剤溶解バルーンの世界市場:主な市販製品

  • SeQuent Please
    • 製品概要・説明
    • 主要技術
    • 過去の臨床研究
    • 現在進行中の治験
  • DIOR Paclitaxel-Eluting Coronary Balloon Catheter
    • 製品概要・説明
    • 主要技術
    • 過去の臨床研究
    • 現在進行中の治験
  • Elutax
    • 製品概要・説明
    • 主要技術
    • 過去の臨床研究
  • Moxy Drug Coated Balloon Catheter
    • 過去の臨床研究
    • 現在進行中の治験

第8章 PTA薬剤溶解バルーンの世界市場:主な市販製品

  • Cotavance
    • 製品概要・説明
    • 主要技術
    • 過去の臨床研究
    • 現在進行中の治験
  • IN.PACT Paclitaxel Eluting Balloon Catheter Series
    • 製品概要・説明
    • 主要技術
    • 過去の臨床研究
    • 現在進行中の治験
  • FREEWAY 014
    • 製品概要・説明
    • 主要技術
    • 過去の臨床研究
    • 現在進行中の治験

第9章 戦略的パイプライン評価

  • パイプライン技術評価
    • PTCA向け開発ステージ別
    • アンメットニーズ別
    • 新規のパイプライン技術評価
  • 臨床開発中の有望製品のプロファイル
    • Advance 18PTX
    • Genesis DESA Catheter
    • Drug-Eluting PTA Balloon Catheter
    • Drug-Eluting Balloon
    • PTCA Balloon Genistein-Coated Balloon Catheter

第10章 戦略的取引分析

  • 主な企業買収
  • 主なパートナーシップ

第11章 付録

図表一覧

目次

Abstract

Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData's new report, "Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global drug eluting balloons market. The report provides market landscape, competitive landscape and market trends information on the drug eluting balloons market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market's dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Key geographies covered include Germany, France, Italy, the UK, Spain, China, Australia and India.
  • Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
  • Qualitative analysis of key market trends, market drivers, and restraints within the drug eluting balloons market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include B Braun, Eurocor and Invatec.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the drug eluting balloons globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • What's the next big thing in the drug eluting balloons market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global drug eluting balloons market and the factors shaping it.

TOC

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 GlobalData Report Guidance 7

3 Major Cardiovascular Indications Approved for Drug Eluting Balloons 8

  • 3.1 In-Stent Restenosis 8
    • 3.1.1 Introduction 8
    • 3.1.2 Pathophysiology 8
    • 3.1.3 Etiology - Risk Factors 9
  • 3.2 In-Stent Restenosis Epidemiology - Global 10
    • 3.2.1 Treatment Flow Model 10
  • 3.3 Peripheral Vascular Disease - Overview and Pathophysiology 12
    • 3.3.1 Introduction 12
  • 3.4 Peripheral Vascular Disease Epidemiology - Global 13
    • 3.4.1 Treatment Flow Model 13
  • 3.5 Peripheral Vascular Disease: Device Based Treatment Modalities and their Outcomes 14

4 Drug Eluting Balloons - Global Market Characterization 16

  • 4.1 Global Drug Eluting Balloons Market, Revenue ($m), 2003-2010 16
  • 4.2 Global Drug Eluting Balloons Market, Revenue ($m), 2010-2017 17
  • 4.3 Global Drug Eluting Balloons Market, Volume (Units), 2007-2010 18
  • 4.4 Global Drug Eluting Balloons Market, Volume (Units), 2010-2017 19
  • 4.5 Global Drug Eluting Balloons, Market Dynamics 20
    • 4.5.1 Market Drivers 20
    • 4.5.2 Market Restraints 23
  • 4.6 Drug Eluting Balloons - Unmet Need and Opportunities 24
    • 4.6.1 Unmet Need 25
    • 4.6.2 Opportunities 25

5 Drug Eluting Balloons Market, by Country, Revenue ($m), Volume, 2003-2017 26

  • 5.1 Germany Drug Eluting Balloons Market, Revenue ($m), 2003-2010 26
  • 5.2 Germany Drug Eluting Balloons Market, Revenue ($m), 2010-2017 27
  • 5.3 Germany Drug Eluting Balloons Market, Volume, 2003-2010 28
  • 5.4 Germany Drug Eluting Balloons Market, Volume, 2010-2017 29
  • 5.5 France Drug Eluting Balloons Market, Revenue ($m), 2003-2010 30
  • 5.6 France Drug Eluting Balloons Market, Revenue ($m), 2010-2017 31
  • 5.7 France Drug Eluting Balloons Market, Volume, 2003-2010 32
  • 5.8 France Drug Eluting Balloons Market, Volume, 2010-2017 33
  • 5.9 Spain Drug Eluting Balloons Market, Revenue ($m), 2003-2010 34
  • 5.10 Spain Drug Eluting Balloons Market, Revenue ($m), 2010-2017 35
  • 5.11 Spain Drug Eluting Balloons Market, Volume, 2003-2010 36
  • 5.12 Spain Drug Eluting Balloons Market, Volume, 2010-2017 37
  • 5.13 Italy Drug Eluting Balloons Market, Revenue ($m), 2003-2010 38
  • 5.14 Italy Drug Eluting Balloons Market, Revenue ($m), 2010-2017 39
  • 5.15 Italy Drug Eluting Balloons Market, Volume, 2003-2010 40
  • 5.16 Italy Drug Eluting Balloons Market,Volume, 2010-2017 41
  • 5.17 The UK Drug Eluting Balloons Market, Revenue ($m), 2003-2010 42
  • 5.18 The UK Drug Eluting Balloons Market, Revenue ($m), 2010-2017 43
  • 5.19 The UK Drug Eluting Balloons Market, Volume, 2003-2010 44
  • 5.20 The UK Drug Eluting Balloons Market, Volume, 2010-2017 45
  • 5.21 Australia Drug Eluting Balloons Market, Revenue ($m), 2003-2010 46
  • 5.22 Australia Drug Eluting Balloons Market, Revenue ($m), 2010-2017 47
  • 5.23 Australia Drug Eluting Balloons Market, Volume, 2003-2010 48
  • 5.24 Australia Drug Eluting Balloons Market,Volume, 2010-2017 49
  • 5.25 China Drug Eluting Balloons Market, Revenue ($m), 2003-2010 50
  • 5.26 China Drug Eluting Balloons Market, Revenue ($m), 2010-2017 51
  • 5.27 China Drug Eluting Balloons Market, Volume, 2003-2010 52
  • 5.28 China Drug Eluting Balloons Market,Volume, 2010-2017 53
  • 5.29 India Drug Eluting Balloons Market, Revenue ($m), 2003-2010 54
  • 5.30 India Drug Eluting Balloons Market, Revenue ($m), 2010-2017 55
  • 5.31 India Drug Eluting Balloons Market, Volume, 2003-2010 56
  • 5.32 India Drug Eluting Balloons Market,Volume, 2010-2017 57

6 Global Drug Eluting Balloons Market - Company Share Analysis and Key Market Participants 58

  • 6.1 Global Drug Eluting Balloons Market, Company Share (%), 2010 58
  • 6.2 B. Braun 59
    • 6.2.1 Overview 59
    • 6.2.2 Drug Eluting Balloons Portfolio 59
  • 6.3 Eurocor 59
    • 6.3.1 Overview 59
  • 6.4 Invatec 60
    • 6.4.1 Overview 60
    • 6.4.2 Drug Eluting Balloons Portfolio 60
  • 6.5 Aachen Resonance GmbH 61
    • 6.5.1 Overview 61
    • 6.5.2 Drug Eluting Balloons Portfolio 61

7 Global PTCA Coronary Drug Eluting Balloons - Key Marketed Products 62

  • 7.1 SeQuent Please 62
    • 7.1.1 Product Overview and Description 62
    • 7.1.2 Key Technology 62
    • 7.1.3 Past Clinical Studies 62
    • 7.1.4 Ongoing Clinical Trials 65
  • 7.2 DIOR Paclitaxel-Eluting Coronary Balloon Catheter 67
    • 7.2.1 Product Overview and Description 67
    • 7.2.2 Key Technology 67
    • 7.2.3 Past Clinical Studies 67
    • 7.2.4 Ongoing Clinical Trials 69
  • 7.3 Elutax 69
    • 7.3.1 Product Overview and Description 69
    • 7.3.2 Key Technology 69
    • 7.3.3 Past Clinical Studies 70
  • 7.4 Moxy Drug Coated Balloon Catheter 70
    • 7.4.2 Past Clinical Studies 70
    • 7.4.3 Ongoing Clinical Trials 71

8 Global PTA Drug Eluting Balloons Market - Key Marketed Products 72

  • 8.1 Cotavance 72
    • 8.1.1 Product Description 72
    • 8.1.2 Key Technology 72
    • 8.1.3 Past Clinical Studies 72
    • 8.1.4 Ongoing Clinical Trials 73
  • 8.2 IN.PACT Paclitaxel Eluting Balloon Catheter Series 74
    • 8.2.1 Product Description 74
    • 8.2.2 Key Technology 74
    • 8.2.3 Past Clinical Studies 74
    • 8.2.4 Ongoing Clinical Trials 75
  • 8.3 FREEWAY 014 75
    • 8.3.1 Product Description 75
    • 8.3.2 Key Technology 75
    • 8.3.3 Past Clinical Studies 75
    • 8.3.4 Ongoing Clinical Study Results 75

9 Global Drug Eluting Balloons Market - Strategic Pipeline Assessment 76

  • 9.1 Pipeline Technology Assessment 76
    • 9.1.1 Pipeline Technology Assessment for Drug Eluting Balloons by Development Stage for PTCA 76
    • 9.1.2 Pipeline Technology Assessment for Drug Eluting Balloons by Unmet Need 78
    • 9.1.3 Novel Pipeline Technology Assessment for Drug Eluting Balloons 79
  • 9.2 Profiles of Promising Products under Clinical Development 80
    • 9.2.1 Advance 18PTX 80
    • 9.2.2 Genesis DESA Catheter 81
    • 9.2.3 Drug-Eluting PTA Balloon Catheter 81
    • 9.2.4 Drug-Eluting Balloon 81
    • 9.2.5 PTCA Balloon Genistein-Coated Balloon Catheter 82

10 Global Drug Eluting Balloons Market - Strategic Deals Analysis 83

  • 10.1 Key Acquisitions 83
    • 10.1.1 Medtronic Acquired Invatec 83
    • 10.1.2 MEDRAD Completes Acquisition of Possis Medical 83
    • 10.1.3 Opto Circuits Acquired Eurocor 83
  • 10.2 Key Partnerships 84
    • 10.2.1 Cardiovascular Systems Enters into an Agreement with Invatec 84
    • 10.2.2 Maxcor Enters into a Strategic Agreement with Micell Technologies 84
    • 10.2.3 Eurocor Enters into a Distribution Agreement with Goodman 84
    • 10.2.4 MEDRAD Enters into Licensing Agreement with B. Braun Melsungen 85
    • 10.2.5 DSM Biomedical and Caliber Therapeutics Form Partnership 85
    • 10.2.6 Aachen Resonance Enters into a Distribution Agreement with Biotronik 85

11 Appendix 86

  • 11.1 Definitions 87
    • 11.1.1 PTCA Coronary Drug Eluting Balloons (DEB) 87
    • 11.1.2 PTA Peripheral Drug Eluting Balloons (DEB) 87
  • 11.2 Acronyms 87
  • 11.3 Sources 88
  • 11.4 Research Methodology 89
    • 11.4.1 Secondary Research 89
    • 11.4.2 Primary Research 89
    • 11.4.3 Models 90
  • 11.5 Expert Panel 90
  • 11.6 GlobalData Consulting 90
  • 11.7 Contact Us 90
  • 11.8 Disclaimer 91

List of Tables

1.1 List of Tables

  • Table 1: Drug Eluting Balloons Market, Global, Revenue ($m), 2003-2010 16
  • Table 2: Drug Eluting Balloons Market, Global, Revenue ($m), 2010-2017 17
  • Table 3: Drug Eluting Balloons Market, Global, Volume (Units), 2007-2010 18
  • Table 4: Drug Eluting Balloons Market, Global, Volume (Units), 2010-2017 19
  • Table 5: Drug Eluting Balloons Clinical Studies Showing Favorable Results 20
  • Table 6: Population Aged 65 and Over, Percentage (%), Global, 2010-2030 22
  • Table 7: Drug Eluting Balloons Clinical Studies Showing Favorable Results 23
  • Table 8: Drug Eluting Balloons Market, Germany, Revenue ($m), 2003-2010 26
  • Table 9: Drug Eluting Balloons Market, Germany, Revenue ($m), 2010-2017 27
  • Table 10: Drug Eluting Balloons Market, Germany, Volume (Absolute), 2003-2010 28
  • Table 11: Drug Eluting Balloons Market, Germany, Volume (Absolute), 2010-2017 29
  • Table 12: Drug Eluting Balloons Market, France, Revenue ($m), 2003-2010 30
  • Table 13: Drug Eluting Balloons Market, France, Revenue ($m), 2010-2017 31
  • Table 14: Drug Eluting Balloons Market, France, Volume (Absolute), 2003-2010 32
  • Table 15: Drug Eluting Balloons Market, France, Volume (Absolute), 2010-2017 33
  • Table 16: Drug Eluting Balloons Market, Spain, Revenue ($m), 2003-2010 34
  • Table 17: Drug Eluting Balloons Market, Spain, Revenue ($m), 2010-2017 35
  • Table 18: Drug Eluting Balloons Market, Spain, Volume (Absolute), 2003-2010 36
  • Table 19: Drug Eluting Balloons Market, Spain, Volume (Absolute), 2010-2017 37
  • Table 20: Drug Eluting Balloons Market, Italy, Revenue ($m), 2003-2010 38
  • Table 21: Drug Eluting Balloons Market, Italy, Revenue ($m), 2010-2017 39
  • Table 22: Drug Eluting Balloons Market, Italy, Volume (Absolute), 2003-2010 40
  • Table 23: Drug Eluting Balloons Market, Italy, Volume (Absolute), 2010-2017 41
  • Table 24: Drug Eluting Balloons Market, The UK, Revenue ($m), 2003-2010 42
  • Table 25: Drug Eluting Balloons Market, The UK, Revenue ($m), 2010-2017 43
  • Table 26: Drug Eluting Balloons Market, The UK, Volume (Absolute), 2003-2010 44
  • Table 27: Drug Eluting Balloons Market, The UK, Volume (Absolute), 2010-2017 45
  • Table 28: Drug Eluting Balloons Market, Australia, Revenue ($m), 2003-2010 46
  • Table 29: Drug Eluting Balloons Market, Australia, Revenue ($m), 2010-2017 47
  • Table 30: Drug Eluting Balloons Market, Australia, Volume (Absolute), 2003-2010 48
  • Table 31: Drug Eluting Balloons Market, Australia, Volume (Absolute), 2010-2017 49
  • Table 32: Drug Eluting Balloons Market, China, Revenue ($m), 2003-2010 50
  • Table 33: Drug Eluting Balloons Market, China, Revenue ($m), 2010-2017 51
  • Table 34: Drug Eluting Balloons Market, China, Volume (Absolute), 2003-2010 52
  • Table 35: Drug Eluting Balloons Market, China, Volume (Absolute), 2010-2017 53
  • Table 36: Drug Eluting Balloons Market, India, Revenue ($m), 2003-2010 54
  • Table 37: Drug Eluting Balloons Market, India, Revenue ($m), 2010-2017 55
  • Table 38: Drug Eluting Balloons Market, India, Volume (Absolute), 2003-2010 56
  • Table 39: Drug Eluting Balloons Market, India, Volume (Absolute), 2010-2017 57
  • Table 40: Drug Eluting Balloons Market, Global, Key Company Shares (%), 2010 58
  • Table 41: B. Braun, Drug Eluting Balloons, Pipeline Products 59
  • Table 42: Eurocor, Drug Eluting Balloons, Pipeline Products 60
  • Table 43: Invatec, Drug Eluting Balloons, Pipeline Products 61
  • Table 44: Aachen Resonance, Drug Eluting Balloons, Pipeline Products 61
  • Table 45: List of Ongoing Clinical Trials, Sequent Please, 2011 65
  • Table 46: List of Ongoing Clinical Trials, DIOR, 2011 69
  • Table 47: List of Ongoing Clinical Trials, Moxy Drug Coated Balloon Catheter, 2011 71
  • Table 48: List of Ongoing Clinical Trials, Cotavance, 2011 73
  • Table 49: List of Ongoing Clinical Trials, IN.PACT Series 75
  • Table 50: List of Ongoing Clinical Trials, FREEWAY 75
  • Table 51: Advance 18 PTX Balloon Catheter - Advance 18PTX Balloon Catheter Study: Treatment of Lesions in Superficial Femoral Artery/Popliteal Artery with a Paclitaxel-Coated Balloon 80

List of Figures

1.2 List of Figures

  • Figure 1: Treatment Flow Model, Drug Eluting Balloons for Treatment of In-Stent Restenosis, Global, 2010 10
  • Figure 2: Device Based Treatment Modalities for In-Stent Restenosis 11
  • Figure 3: Treatment Flow Model, Drug Eluting Balloons for Treatment of Peripheral Artery Disease, Global, 2010 13
  • Figure 4: Device Based Treatment Modalities for Peripheral Vascular Disease 14
  • Figure 5: Drug Eluting Balloons Market, Global, Revenue ($m), 2003-2010 16
  • Figure 6: Drug Eluting Balloons Market, Global, Revenue ($m), 2010-2017 17
  • Figure 7: Drug Eluting Balloons Market, Global, Volume (Units), 2007-2010 18
  • Figure 8: Drug Eluting Balloons Market, Global, Volume (Units), 2010-2017 19
  • Figure 9: Population Aged 65 and Over, Percentage (%), Global, 2010-2030 22
  • Figure 10: Unmet Need and Opportunities Analysis for Drug Eluting Balloons 24
  • Figure 11: Drug Eluting Balloons Market, Germany, Revenue ($m), 2003-2010 26
  • Figure 12: Drug Eluting Balloons Market, Germany, Revenue ($m), 2010-2017 27
  • Figure 13: Drug Eluting Balloons Market, Germany, Volume (Absolute), 2003-2010 28
  • Figure 14: Drug Eluting Balloons Market, Germany, Volume (Absolute), 2010-2017 29
  • Figure 15: Drug Eluting Balloons Market, France, Revenue ($m), 2003-2010 30
  • Figure 16: Drug Eluting Balloons Market, France, Revenue ($m), 2010-2017 31
  • Figure 17: Drug Eluting Balloons Market, France, Volume (Absolute), 2003-2010 32
  • Figure 18: Drug Eluting Balloons Market, France, Volume (Absolute), 2010-2017 33
  • Figure 19: Drug Eluting Balloons Market, Spain, Revenue ($m), 2003-2010 34
  • Figure 20: Drug Eluting Balloons Market, Spain, Revenue ($m), 2010-2017 35
  • Figure 21: Drug Eluting Balloons Market, Spain, Volume (Absolute), 2003-2010 36
  • Figure 22: Drug Eluting Balloons Market, Spain, Volume (Absolute), 2010-2017 37
  • Figure 23: Drug Eluting Balloons Market, Italy, Revenue ($m), 2003-2010 38
  • Figure 24: Drug Eluting Balloons Market, Italy, Revenue ($m), 2010-2017 39
  • Figure 25: Drug Eluting Balloons Market, Italy, Volume (Absolute), 2003-2010 40
  • Figure 26: Drug Eluting Balloons Market, Italy, Volume (Absolute), 2010-2017 41
  • Figure 27: Drug Eluting Balloons Market, The UK, Revenue ($m), 2003-2010 42
  • Figure 28: Drug Eluting Balloons Market, The UK , Revenue ($m), 2010-2017 43
  • Figure 29: Drug Eluting Balloons Market, The UK, Volume (Absolute), 2003-2010 44
  • Figure 30: Drug Eluting Balloons Market, The UK, Volume (Absolute), 2010-2017 45
  • Figure 31: Drug Eluting Balloons Market, Australia, Revenue ($m), 2003-2010 46
  • Figure 32: Drug Eluting Balloons Market, Australia, Revenue ($m), 2010-2017 47
  • Figure 33: Drug Eluting Balloons Market, Australia, Volume (Absolute), 2003-2010 48
  • Figure 34: Drug Eluting Balloons Market, Australia, Volume (Absolute), 2010-2017 49
  • Figure 35: Drug Eluting Balloons Market, China, Revenue ($m), 2003-2010 50
  • Figure 36: Drug Eluting Balloons Market, China, Revenue ($m), 2010-2017 51
  • Figure 37: Drug Eluting Balloons Market, China, Volume (Absolute), 2003-2010 52
  • Figure 38: Drug Eluting Balloons Market, China, Volume (Absolute), 2010-2017 53
  • Figure 39: Drug Eluting Balloons Market, India, Revenue ($m), 2003-2010 54
  • Figure 40: Drug Eluting Balloons Market, India, Revenue ($m), 2010-2017 55
  • Figure 41: Drug Eluting Balloons Market, India, Volume (Absolute), 2003-2010 56
  • Figure 42: Drug Eluting Balloons Market, India, Volume (Absolute), 2010-2017 57
  • Figure 43: Drug Eluting Balloons Market, Global, Company Share (%), 2010 58
  • Figure 44: Pipeline Technology Assessment for PTCA Coronary Drug Eluting Balloons by Development Stage, Europe, 2011 76
  • Figure 45: Pipeline Technology Assessment for PTA Drug Eluting Balloons by Development Stage, Europe, 2011 77
  • Figure 46: Pipeline Technology Assessment for Drug Eluting Balloons by Unmet Need 78
Back to Top